Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rieske, P
Right arrow Articles by Liberski, P P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rieske, P
Right arrow Articles by Liberski, P P
Molecular Pathology 2003;56:299-301
© 2003 BMJ Publishing Group Ltd. & Association of Clinical Pathologists


SHORT REPORT

Molecular heterogeneity of meningioma with INI1 mutation

P Rieske1, M Zakrzewska1, S Piaskowski1, D Jaskólski2, B Sikorska1, W Papierz3, K Zakrzewski4 and P P Liberski1

1 Department of Molecular Pathology and Neurology, Medical University, 92–216 Lodz, Poland
2 Department of Neurosurgery, Medical University
3 Department of Pathomorphology, Medical University
4 Department of Neurosurgery, Polish Mother’s Memorial Hospital, 93–338 Lodz, Poland

Correspondence to:
Dr P Rieske, Department of Molecular Pathology and Neuropathology, Medical University Lodz, Czechoslowacka st.8/10, 92–216 Lodz, Poland;
Rieske{at}excite.com


ABSTRACT
Background: INI1 (hSNF5) mutations are linked to rhabdoid tumours, but mutations in meningiomas with hot spot mutations in position 377 have also been reported.

Aims: To analyse the INI1 gene in meningioma.

Methods: Exons 1, 4, 5, and 9 of the INI1 gene were analysed by the polymerase chain reaction and direct sequencing in 80 meningiomas. For all cases, western blotting of the INI1 protein was performed.

Results: Only one of the 80 samples showed a cytosine insertion in codon 376. This mutation changed the open reading frame in almost the whole exon 9 and resulted in a longer hSNF5 protein. Complex analysis of the above described tumour sample by western blotting, DNA sequencing, and loss of heterozygosity (LOH) analysis showed that this particular meningioma consisted of heterogeneic cellular components. One of these components had a mutated INI1 gene, whereas in the other component INI1 was intact.

Conclusions: INI1 mutation is a rare event in the molecular pathology of meningiomas. It is possible for the INI1 gene to be mutated in only a proportion of meningioma cells.


Keywords: loss of heterozygosity; meningioma; molecular heterogeneity; INI1; hSNF5

Abbreviations: LOH, loss of heterozygosity; NES, nuclear export signal; NF2, neurofibromin 2; INI1, integrase interactor 1; PCR, polymerase chain reaction







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.